Erang, Jonathan .
HRN: 26-93-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2025
CEFUROXIME 750MG (VIAL)
04/07/2025
04/14/2025
IV
750
Q8
Fracture Close Complete Supracondylar L
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes